CPRX

CPRX R&D to Revenue

2.16%Fiscal year

Period ending:

CPRX FY R&D/Revenue%
CPRX FY R&D/Revenue4461.90%-478.06%
2002-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CPRX r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 24 observations from Dec 31, 2002 to Dec 31, 2025.

Catalyst Pharmaceuticals Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
2.1578%
2.5721%
23.3925%
9.2384%
12.0256%
13.8545%
18.4183%
3,983.8408%
0%
0%
0%
0%
0%
0%
0%
471.7749%
0%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All CPRX financial metrics · CPRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.